Prostate Cancer

Top Story

University of Michigan prostate cancer risk clinic may make ‘dramatic impact’ on disease burden, mortality

University of Michigan prostate cancer risk clinic may make ‘dramatic impact’ on disease burden, mortality
March 27, 2017

The University of Michigan has opened a center designed to provide individualized, structured care for men with a genetic predisposition to prostate cancer.

The Prostate Cancer Risk Clinic — which opened in early March — emerged from research that elucidated the significant role that genetic mutations play in prostate cancer risk.

‘We can do better’: ASCO report outlines persistent health care disparities, need for funding

March 22, 2017
Over the next 10 years, the number of cancer survivors in the United States is expected to grow from 15.5 million to 20.3 million, according to ASCO’s State of
Point/Counter

Is genetic testing sophisticated enough to make PSA screening viable for mainstream use?

HemOnc Today, March 25, 2017
POINT Improvements in biomarkers and genetic tests have refined screening methods to reduce unnecessary biopsies and overdetection of indolent disease. The underlying…
Cover Story

Active surveillance, physician–patient communication may redefine role of PSA testing

HemOnc Today, March 25, 2017
Most men diagnosed with prostate cancer will not die of the disease. Even so, it remains the second-leading cause of cancer mortality among American men, accounting for…
CME

Immuno-Oncology Forum: Focus on Non-Small Cell Lung Cancer

This activity is supported by educational grants from Bristol-Myers Squibb; Genentech, Inc.; and Merck & Co., Inc.

Lung cancer accounts for 27% of all cancer deaths in the United States, making it the leading cause of cancer…
More »
Video

VIDEO: Emerging data on checkpoint blockades suggest potential ‘cure’ for certain tumors, not all cancer

May 16, 2016
More »
Featured
HEMONC TODAY Melanoma and Cutaneous Malignancies

HEMONC TODAY Melanoma and Cutaneous Malignancies

CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to…
More »

University of Michigan prostate cancer risk clinic may make ‘dramatic impact’ on disease burden, mortality

March 27, 2017
The University of Michigan has opened a center designed to provide individualized, structured care for men with a genetic predisposition to prostate…

‘We can do better’: ASCO report outlines persistent health care disparities, need for funding

March 22, 2017
Over the next 10 years, the number of cancer survivors in the United States is expected to grow from 15.5 million to 20.3 million, according to…

Point/Counter

Is genetic testing sophisticated enough to make PSA screening viable for mainstream use?

HemOnc Today, March 25, 2017
POINT Improvements in biomarkers and genetic tests have refined screening methods to reduce unnecessary biopsies and overdetection of indolent disease…

Cover Story

Active surveillance, physician–patient communication may redefine role of PSA testing

HemOnc Today, March 25, 2017
Most men diagnosed with prostate cancer will not die of the disease. Even so, it remains the second-leading cause of cancer mortality among American…

In the Journals PlusPerspective

Localized prostate cancer treatment options lead to different sexual functioning, quality-of-life outcomes

March 21, 2017
Men with localized prostate cancer experienced different adverse events and quality-of-life changes according to whether they underwent surgery…

In the Journals

Cancer surveillance guidelines lack specificity, consistency

March 20, 2017
Recommendations for surveillance after cancer treatment in survivors across guidelines are often nonspecific and inconsistent; therefore…

Leading cancer organizations: Trump’s proposed NIH budget cuts will threaten research, patient care

March 17, 2017
Many of the nation’s leading research organizations and cancer centers have voiced their opposition to President Donald J. Trump’s…

Open-access ‘knowledgebase’ focuses on clinical relevance of cancer gene mutations

March 16, 2017
Cancer researchers at Washington University School of Medicine in St. Louis have developed an online cancer database designed to streamline the…

Perspective

White paper outlines progress, challenges of immunotherapy in community setting

March 15, 2017
The Association of Community Cancer Centers’ Institute for Clinical Immuno-Oncology issued a white paper titled “Immuno-Oncology…

Learn Immuno-Oncology New York scheduled for March 23

March 15, 2017
Learn Immuno-Oncology New York, an interactive educational event focused on the rapidly evolving future of cancer treatment, will be held March 23 at…

More Headlines »
Advertisement
Advertisement